Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus

被引:0
|
作者
Krzysztof Domagalski [1 ]
Ma?gorzata Paw?owska
Agnieszka Zale?na
Ma?gorzata Pilarczyk
Pawe? Rajewski
Waldemar Halota [2 ]
Andrzej Tretyn [4 ]
机构
[1] Centre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University
[2] Provincial Infectious Diseases Hospital in Bydgoszcz  4. Department of Plant Physiology and Biotechnology, Nicolaus Copernicus University
[3] Department of Paediatric Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Torun
关键词
Chronic hepatitis B; IL28B; OAS; Singlenucleotide polymorphisms; IFN therapy; Children;
D O I
暂无
中图分类号
R725.1 [小儿传染病];
学科分类号
100202 ;
摘要
AIM To investigate the impact of IL28 B and OAS gene polymorphisms on interferon treatment responses in children with chronic hepatitis B.METHODS We enrolled 52 children(between the ages of 4 and 18) with hepatitis B e antigen-negative chronic hepatitis B(CHB), who were treated with pegylated interferon alfa for 48 wk. Single nucleotide polymorphisms in the OAS1(rs1131476), OAS2(rs1293747),OAS3(rs2072136), OASL(rs10849829) and IL28B(rs12979860, rs12980275 and rs8099917) genes were studied to examine their associations with responses to IFN treatment in paediatric patients. We adopted two criteria for the therapeutic response, achieving an hepatitis B virus(HBV) DNA level < 2000 IU/m L and normalization of ALT activity(< 40 IU/L). To perform the analyses, we compared the patients in terms of achieving a partial response(PR) and a complete response(CR) upon measurement at the 24-wk posttreatment follow-up. RESULTS The PR and CR rates were 80.8% and 42.3%, respectively. Factors such as age, gender and liver histology had no impact on the type of response(partial or complete). A statistically significant relationship between higher baseline HBV DNA and ALT activity levels and lower rates of PR and CR was shown(P < 0.05). The allele association analysis revealed that only the IL-28 B rs12979860(C vs T) and IL28 B rs12980275(A vs G) markers significantly affected the achievement of PR(P = 0.021, OR = 3.3, 95%CI: 1.2-9.2 and P = 0.014, OR = 3.7, 95%CI: 1.3-10.1, respectively). However, in the genotype analysis, only IL-28 B rs12980275 was significantly associated with PR(AA vs AG-GG, P = 0.014, OR = 10.9, 95%CI: 1.3-93.9). The association analysis for CR showed that the TT genotype of IL28 B rs12979860 was present only in the no-CR group(P = 0.033) and the AA genotype of OASL rs10849829 was significantly more frequent in the noCR group(P = 0.044, OR = 0.26, 95%CI: 0.07-0.88). The haplotype analysis revealed significant associations between PR and CR and OAS haplotype(P = 0.0002 and P = 0.001, respectively), but no association with IL28 B haplotype was observed.CONCLUSION IL28 B and OAS polymorphisms are associated with different clinical outcomes in CHB children treated with interferon.
引用
收藏
页码:9186 / 9195
页数:10
相关论文
共 50 条
  • [11] IL28B single nucleotide polymorphisms in the treatment of hepatitis C
    Lange, Christian M.
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2011, 55 (03) : 692 - 701
  • [12] The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C
    Lazarevic, Ivana
    Djordjevic, Jelena
    Cupic, Maja
    Karalic, Danijela
    Delic, Dragan
    Svirtlih, Neda
    Simonovic, Jasmina
    Svorcan, Petar
    Milic, Natasa
    Jovanovic, Tanja
    JOURNAL OF CLINICAL VIROLOGY, 2013, 58 (01) : 254 - 257
  • [13] IL28B Polymorphisms as a Pretreatment Predictor of Response to HCV Treatment
    Berger, Christoph T.
    Kim, Arthur Y.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2012, 26 (04) : 863 - +
  • [14] Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients
    Dzekova-Vidimliski, Pavlina
    Nikolov, Igor G.
    Matevska-Geshkovska, Nadica
    Mena, Sami
    Rostaing, Lionel
    Dimovski, Aleksandar
    Sikole, Aleksandar
    RENAL FAILURE, 2015, 37 (07) : 1180 - 1184
  • [15] Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin
    Lyoo, KwangSoo
    Song, Myeong Jun
    Hur, Wonhee
    Choi, Jung Eun
    Hong, Sung Woo
    Kim, Chang Wook
    Bae, Si Hyun
    Choi, Jong Young
    Choi, Sang Wook
    Shin, Eui-Cheol
    Yoon, Seung Kew
    JOURNAL OF CLINICAL VIROLOGY, 2011, 52 (04) : 363 - 366
  • [16] Sequence Analysis of the IL28A/IL28B Inverted Gene Duplication That Contains Polymorphisms Associated with Treatment Response in Hepatitis C Patients
    Reynolds, Jennifer M.
    Paciga, Sara A.
    Sanders, Frances A.
    Hyde, Craig L.
    Loomis, A. Katrina
    Johnston, Geoffrey I.
    PLOS ONE, 2012, 7 (01): : 271 - 278
  • [17] Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B
    Wu, Haiqing
    Zhao, Gangde
    Qian, Fangxing
    Liu, Kehui
    Xie, Jingdong
    Zhou, Huijuan
    Xu, Jie
    Xu, Yumin
    Han, Yan
    Xie, Qing
    Wang, Hui
    LIVER INTERNATIONAL, 2015, 35 (02) : 473 - 481
  • [18] Polymorphisms in the IL28B gene (rs12979860, rs8099917) and the virological response to pegylated interferon therapy in hepatitis D virus patients
    Yilmaz, Bulent
    Can, Guray
    Ucmak, Feyzullah
    Arslan, Ali Osman
    Solmaz, Ihsan
    Unlu, Ozan
    Duzenli, Selma
    Korkmaz, Ugur
    Kurt, Mevlut
    Senates, Ebubekir
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2016, 79 (02): : 206 - 210
  • [19] IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
    Rallon, Norma I.
    Soriano, Vincent
    Naggie, Susanna
    Restrepo, Clara
    Goldstein, David
    Vispo, Eugenia
    McHutchison, John
    Benito, Jose M.
    AIDS, 2011, 25 (08) : 1025 - 1033
  • [20] IL28B and the Control of Hepatitis C Virus Infection
    Balagopal, Ashwin
    Thomas, David L.
    Thio, Chloe L.
    GASTROENTEROLOGY, 2010, 139 (06) : 1865 - 1876